Table 4.
Values obtained with pulse wave velocity and applanation tonometry
| Variables | Losartan group (n = 21) | Amlodipine group (n = 21) | p-value |
|---|---|---|---|
| CR-PWV, m/s | 9.9 ± 1.1 | 9.5 ± 1.4 | 0.347 |
| CF-PWV, m/s | 10.4 ± 2.2 | 10.6 ± 2.7 | 0.880 |
| NCF-PWV, m/s | 9.5 ± 1.8 | 9.8 ± 2.5 | 0.595 |
| ASBP, mmHg | 144 ± 19 | 136 ± 12 | 0.108 |
| ADBP, mmHg | 90 ± 10 | 84 ± 10 | 0.100 |
| PI, mmHg | 20 ± 8 | 16 ± 6 | 0.045 |
| AIx, % | 36 ± 8 | 30 ± 9 | 0.025 |
| APP, mmHg | 53 ± 16 | 49 ± 11 | 0.386 |
| AIx@75, % | 32 ± 7 | 28 ± 7 | 0.050 |
Data are expressed as mean ± standard deviation. AIx: augmentation index; AP: augmentation pressure; AIx@75: augmentation index corrected for a heart rate of 75 bpm; ADBP: aortic diastolic blood pressure; ASBP: aortic systolic blood pressure; APP: aortic pulse pressure; CF-PWV: carotid-femoral pulse wave velocity; NCF-PWV: normalized carotid-femoral pulse wave velocity; CR-PWV: carotid-radial pulse wave velocity. The p-values were calculated using Student's t test.